President Trump's administration has cut $258 million from the HHS budget that supported HIV vaccine research programs at Duke Human Vaccine Institute and Scripps Research Institute. Officials cited duplication of existing health programs as the reason for not renewing funding, claiming that HHS has already spent $7.5 billion on HIV/AIDS research. Critics, including researchers involved in the studies, express concern that this decision may halt promising advancements in HIV vaccine design and development just as significant progress is being made in clinical trials.
President Trump has cut $258 million from the HHS budget, impacting vital research for an HIV vaccine, which has shown promise in recent years.
HHS officials stated the decision to cut funding is based on existing duplications in HIV research, believing current efforts should be prioritized.
Collection
[
|
...
]